Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2585-23-1

Post Buying Request

2585-23-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2585-23-1 Usage

General Description

N-Methyl-4-Nitro-Benzamide is a chemical compound with the molecular formula C8H8N2O3. It is a yellow crystalline solid that is commonly used as an intermediate in the production of pharmaceuticals and agrochemicals. N-Methyl-4-Nitro-Benzamide is known for its nitro group, which can act as a strong oxidizing agent in certain reactions. N-Methyl-4-Nitro-Benzamide is also used as a reagent in organic synthesis and as a precursor to various other chemicals. It should be handled with care due to its potential reactivity and toxicity.

Check Digit Verification of cas no

The CAS Registry Mumber 2585-23-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,8 and 5 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 2585-23:
(6*2)+(5*5)+(4*8)+(3*5)+(2*2)+(1*3)=91
91 % 10 = 1
So 2585-23-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N2O3/c1-9-8(11)6-2-4-7(5-3-6)10(12)13/h2-5H,1H3,(H,9,11)

2585-23-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name N-methyl-4-nitrobenzamide

1.2 Other means of identification

Product number -
Other names p-nitro-benzoic acid N-methyl amide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2585-23-1 SDS

2585-23-1Relevant articles and documents

Trifluoroacetic Acid Hydroxylamine System as Organocatalyst Reagent in a One-Pot Salt Free Process for the Synthesis of Caprolactam and Amides of Industrial Interest

Manente,Pietrobon,Ronchin,Vavasori

, p. 3543 - 3549 (2021/03/30)

In this work we studied the reactivity of the Trifluoroacetic acid hydroxylamine system in the one step salt free synthesis of amides from ketones. A particular regards was paid to the caprolactam synthesis because of its industrial relevance. Synthesis, reactivity and characterization of the hydroxylamine trifluoroacetate is given. Fast oximation reaction of several ketones was gained at room temperature (1?h of reaction quantitative conversion for several ketones). In the same reactor, by raising the temperature at 383?K, the Beckmann rearrangement of the so obtained oximes is easily accomplished in the presence of three equivalent of TFA. The possibility of obtaining the trifluoroacetate of the hydroxylamine with a modified nitric acid hydrogenation reactions was verified, too. Reuse of solvent and trifluoroacetic acid is easily achieved by distillation. Graphical abstract: Salt free one-pot caprolactam and amides process catalyzed by CF3COOH, in the presence of NH2OH TFA as the oximation agent.[Figure not available: see fulltext.].

2-(4-methanoyl) anilino-4-aminopyrimidine derivatives and application thereof

-

Paragraph 0031-0036, (2021/04/03)

The invention belongs to the technical field of chemical medicines, and particularly relates to 2-(4-methanoyl) anilino-4-aminopyrimidine derivatives and application thereof. According to the invention, nitryl, carboxyl, cyano and the like are adopted to

4, 6-disubstituted pyridine [3, 2-d] pyrimidine compound as well as preparation and application thereof

-

Paragraph 0403-0406, (2020/04/02)

The invention belongs to the technical field of medicines. The invention relates to the field of pharmaceutical chemistry, in particular to a 4, 6-disubstituted pyridine [3, 2-d] pyrimidine compound and pharmaceutically acceptable salt thereof, a preparation method of the compound, a pharmaceutical composition taking the compound as an active ingredient, and application of the compound in preparation of an MNK inhibitor and drugs for treating and/or preventing various cancers and/or metabolic diseases. The present invention relates to compounds represented by formulas I, II, III or IV, and pharmaceutically acceptable salts, hydrates, solvates and metabolites thereof, wherein the variables are described in the claims and the description.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2585-23-1